ABSTRACT To determine whether refractoriness to histamine induced bronchoconstriction occurs, 20 asthmatic subjects aged 19-50 years were tested. Subjects underwent two histamine challenge tests (1 and 2) on the same day, the second one being given [45][46][47][48][49][50][51][52][53][54][55][56][57][58][59][60] 
Introduction
Controlled provocation of bronchoconstriction by chemical and physical stimuli is widely used in the investigation of asthma. Immediate refractoriness to further bronchoconstriction has been shown to occur when the initial constrictive episode is provoked by stimuli such as exercise'; hyperventilation2; or the inhalation of ultrasonically nebulised distilled water,3 leukotriene D4,4 and platelet activating factor.5 With methacholine the long duration of action makes the investigation of refractoriness difficult. Refractoriness after methacholine provoked bronchoconstriction has, nevertheless, been reported by some investigators though not others.67
Histamine has been the subject of more detailed study, though data are still limited and conflicting. In 1980 Schoeffel et al found progressively smaller mean decrements in peak expiratory flow (38%, 34%, and 29%) in 16 asthmatic subjects after inhalation of identical doses of histamine at 40 minute intervals.8
This initial hint of refractoriness after histamine
Address for reprint requests: Dr D J Hendrick, Newcastle General Hospital, Newcastle upon Tyne NE4 6BE. Accepted 27 November 1988 challenge tests has been supported by recent reportsthose of Manning and colleagues,9 10 who retested 11 and eight subjects respectively after 60 minutes using the continuous (Wright) nebulisation method, and of Magnussen and colleagues, who retested nine subjects after 60 minutes using airway resistance to measure bronchial responsiveness.6 Controversy has arisen, however, because other studies, using a similar range of methods, have failed to show significant decreases in bronchial responsiveness with closely repeated histamine tests."-" We present the results of a study in 20 adults with asthma.
Methods

SUBJECTS
Twenty subjects (9 male, 11 female) with symptomatic asthma and reversible airway obstruction were recruited from our clinic and student populations. They were not told the purpose of the study. The age range was (2 20) to the amended refractory index (1-75) was also significantly different from 1 (p = 0.013).
RELATION BETWEEN REFRACTORINESS AND PD20
The relation between the refractory index (PD20 test 2: PD2,0 test 1) in each subject and the geometric mean PD20 values from the control test and test 1 is shown in figure 2 . All 14 subjects with a mean PD20 above 25 pg showed a refractory index greater than 1. When the amended PD20 test 2 values were used, the refractory index consistently exceeded 1 when the mean PD20 was above 100 pg.
Discussion
This study has found a diminished bronchoconstrictor response to histamine in most of the 20 asthmatic subjects given a second histamine inhalation test 45-60 minutes after an initial test. We therefore support the Refractory periodfollowing bronchoconstriction provoked by histamine in asthmatic subjects suggestion that histamine provoked bronchoconstriction induces refractoriness, at least in some individuals. A refractory index exceeding 1 was not observed uniformly with high levels of bronchial responsiveness (that is, low PD20 values), however, and our results suggest a possible PDO threshold of the order of 25-100 tg histamine. Above this threshold the refractory index did not appear to be related to PD20, implying that other factors help to determine the degree of refractoriness, once the PD20 (and dose of histamine) are sufficiently high for refractoriness to occur.
The failure of some investigations to show refractoriness is unexplained-unless the subjects in these studies had high levels of airway responsiveness. Adequate numbers of subjects and reasonable precision in the measurement of PD20 are necessary if refractoriness is to be recognised, and baseline levels of ventilatory function should be closely similar for the paired tests. Investigations measuring bronchial responsiveness by means other than the PD20FEV, may not produce as much bronchoconstriction (or give as much histamine), and this too could minimise the refractory effect. Finally, it is not always clear that studies failing to detect a refractory period were carried out on typical asthmatic subjects rather than subjects with relatively fixed airway obstruction attributable to cigarette smoking."
The magnitude of the refractory effect generated by a single histamine test was appreciable though not substantial, the median refractory index being 2 20 (range 0-24-6-1). The range observed above the "threshold" of refractoriness was 1 3-6 1. Refractoriness ofthis degree could exert an important confounding effect when histamine challenge tests are used repeatedly within a single day to measure bronchial responsiveness. For example, bronchial responsiveness to histamine was shown to increase 1 to 2 hours after exposure to respirable industrial agents associated with occupational asthma, before the onset of the ensuing late asthmatic reactions.-' Refractoriness here would have diminished the true magnitude of this effect and could have masked it. Investigations showing an apparent circadian rhythm in bronchial responsiveness from frequently repeated histamine tests at uneven intervals may have been subjected to both masking and exaggerating distortions because of the refractory effect. The duration of the refractory period, which Manning et al estimated to be of the order of three to six hours, is obviously a critical factor.9 Until this is established, the importance and strength of the refractory effect as a confounding factor will remain unclear.
It is improbable that our observations could have been generated by an artefact in the histamine delivery system. Ifthe nebuliser is used continuously, its output may be expected to decline owing to cooling, but with intermittent use this is unlikely and we have found no evidence of it in practice. A further possible artefact from repeated nebuliser use is increasing concentration of the histamine solution from evaporation. This is unlikely to be important when solutions are replaced daily, as was the practice in this study. In any event, increasing concentration would tend to mask, not exaggerate, refractoriness. Our findings are supported by observations that both canine24 and human25 airway smooth muscle readily develop refractoriness to repeated stimulation with histamine in vitro. Depletion of mediator stores in mast cells, which has been proposed as the mechanism for exercise induced refactoriness,26 is not likely to be relevant to histamine induced refractoriness. The fact that some degree of refractoriness has been found in response to a wide range of directly and indirectly acting bronchoconstrictors suggests that changes in the end organ (that is, the airway smooth muscle itself) might be responsible. In the dog this appears to be mediated by a bronchorelaxant prostaglandin, probably PGE2.2' The same mechanism may be responsible for histamine tachyphylaxis in human airways,9 where indomethacin has been shown to increase the steepness of inhaled histamine dose-response curves. 28 MJC was supported by the Newcastle Health Authority research commitee.
